Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer

RecruitingOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

April 17, 2019

Primary Completion Date

April 30, 2029

Study Completion Date

April 30, 2029

Conditions
Cancer
Interventions
OTHER

Family History Information

The family history ascertainment focuses on self-reported family history of first-, second-, and third-degree family members, including types of malignancies/ pre-malignant lesions and age at diagnosis.

GENETIC

ORAGENE

Approximately 2-4mL of saliva may be collected in specialized Oragene DNA Self-Collection Kit tubes or buccal swab-based collection devices.

GENETIC

Blood

For select participants, 1-2 tubes of blood will be drawn for DNA and RNA analysis

OTHER

Skin Biopsy

In certain circumstances, for Memorial Sloan Kettering participants and their family members, it may be necessary to obtain a skin biopsy.

Trial Locations (7)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

10604

RECRUITING

Memorial Sloan Kettering Westchester (Consent only), Harrison

11553

RECRUITING

Memorial Sloan Kettering Nassau (Consent only), Uniondale

11725

RECRUITING

Memorial Sloan Kettering Cancer Center @ Commack (Consent Only), Commack

07920

RECRUITING

Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge

07748

RECRUITING

Memorial Sloan Kettering Monmouth (Consent only), Middletown

07645

RECRUITING

Memorial Sloan Kettering Bergen (Consent only ), Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER